Dr Reddy's Laboratories (BSP:R1DY34) Days Sales Outstanding : 94.13 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Dr Reddy's Laboratories Days Sales Outstanding?

Dr Reddy's Laboratories's average Accounts Receivable for the three months ended in Dec. 2023 was R$4,380 Mil. Dr Reddy's Laboratories's Revenue for the three months ended in Dec. 2023 was R$4,246 Mil. Hence, Dr Reddy's Laboratories's Days Sales Outstanding for the three months ended in Dec. 2023 was 94.13.

The historical rank and industry rank for Dr Reddy's Laboratories's Days Sales Outstanding or its related term are showing as below:

BSP:R1DY34' s Days Sales Outstanding Range Over the Past 10 Years
Min: 89.76 Med: 96.46 Max: 103.36
Current: 100.3

During the past 13 years, Dr Reddy's Laboratories's highest Days Sales Outstanding was 103.36. The lowest was 89.76. And the median was 96.46.

BSP:R1DY34's Days Sales Outstanding is ranked worse than
74.13% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.68 vs BSP:R1DY34: 100.30

Dr Reddy's Laboratories's Days Sales Outstanding declined from Dec. 2022 (103.88) to Dec. 2023 (94.13).

Dr Reddy's Laboratories Days Sales Outstanding Historical Data

The historical data trend for Dr Reddy's Laboratories's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Days Sales Outstanding Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

91.24

87.69

88.72

106.90

104.92

Dr Reddy's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															103.88	107.14	104.84	97.00	94.13

Competitive Comparison of Dr Reddy's Laboratories's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Reddy's Laboratories's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's Days Sales Outstanding falls into.

Dr Reddy's Laboratories Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Dr Reddy's Laboratories's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (4360.757	+	4589.297)	/	2 )	/	15567.52	*	365
=	4475.027					/	15567.52	*	365
=	104.92

Dr Reddy's Laboratories's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4145.131	+	4615.125)	/	2 )	/	4246.172	*	365 / 4
=	4380.128					/	4246.172	*	365 / 4
=	94.13

Dr Reddy's Laboratories (BSP:R1DY34) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Dr Reddy's Laboratories Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (BSP:R1DY34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (BSP:R1DY34) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

RDY:USA DRREDDY:India 500124:India RDDA:Germany RDDA:Germany

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories (BSP:R1DY34) Headlines

No Headlines